1. Home
  2. ALKS vs BIPC Comparison

ALKS vs BIPC Comparison

Compare ALKS & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • BIPC
  • Stock Information
  • Founded
  • ALKS 1987
  • BIPC 2019
  • Country
  • ALKS Ireland
  • BIPC United States
  • Employees
  • ALKS N/A
  • BIPC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • BIPC Marine Transportation
  • Sector
  • ALKS Health Care
  • BIPC Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • BIPC Nasdaq
  • Market Cap
  • ALKS 5.0B
  • BIPC 4.8B
  • IPO Year
  • ALKS 1991
  • BIPC N/A
  • Fundamental
  • Price
  • ALKS $29.21
  • BIPC $44.25
  • Analyst Decision
  • ALKS Strong Buy
  • BIPC Hold
  • Analyst Count
  • ALKS 13
  • BIPC 1
  • Target Price
  • ALKS $42.54
  • BIPC $46.00
  • AVG Volume (30 Days)
  • ALKS 2.1M
  • BIPC 613.6K
  • Earning Date
  • ALKS 10-28-2025
  • BIPC 01-01-0001
  • Dividend Yield
  • ALKS N/A
  • BIPC 3.87%
  • EPS Growth
  • ALKS 21.99
  • BIPC N/A
  • EPS
  • ALKS 2.08
  • BIPC N/A
  • Revenue
  • ALKS $1,505,296,000.00
  • BIPC $3,651,000,000.00
  • Revenue This Year
  • ALKS N/A
  • BIPC $3.27
  • Revenue Next Year
  • ALKS $1.59
  • BIPC $5.78
  • P/E Ratio
  • ALKS $14.32
  • BIPC N/A
  • Revenue Growth
  • ALKS N/A
  • BIPC 11.38
  • 52 Week Low
  • ALKS $25.17
  • BIPC $32.08
  • 52 Week High
  • ALKS $36.45
  • BIPC $47.71
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 42.95
  • BIPC 53.02
  • Support Level
  • ALKS $29.94
  • BIPC $43.50
  • Resistance Level
  • ALKS $32.02
  • BIPC $45.19
  • Average True Range (ATR)
  • ALKS 1.13
  • BIPC 1.15
  • MACD
  • ALKS -0.32
  • BIPC -0.25
  • Stochastic Oscillator
  • ALKS 9.12
  • BIPC 17.81

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BIPC Brookfield Infrastructure Corporation

Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.

Share on Social Networks: